Although PV carriers have high disease penetrance (<i>BRCA1</i>: ~40% and <i>BRCA2</i>: 11-27%), substantial variability in individual risk is observed, suggesting the influence of additional genetic variants. This evidence concerns the gene BRCA2 and acquired polycythemia vera.